FDA Adverse Event Injury Summary report: N

ILET BIONIC PANCREAS

MDR report key: 24431483 · Received February 24, 2026

Report

Report Number
3019004087-2026-32630
Event Type
Injury
Date Received
February 24, 2026
Date of Event
January 29, 2025
Report Date
February 24, 2026
Manufacturer
BETA BIONICS INC.
Product Code
QFG
UDI-DI
00850050080183
PMA / PMN Number
K231485
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THIS MDR IS PART OF A REMEDIAL SUBMISSION MADE IN RESPONSE TO FDA FORM 483 OBSERVATIONS TO ENSURE FULL REPORTING COMPLIANCE.

Description of Event or Problem · 0

IT WAS REPORTED THAT A USER BEGAN INITIAL ILET TRAINING, USED APPROXIMATELY 80 UNITS OF INSULIN DURING THE SESSION, CHANGED THE CARTRIDGE, AND LATER EXPERIENCED HYPERGLYCEMIA WITH GLUCOSE READINGS IN THE 200¿320 MG/DL RANGE WHILE THE DEVICE CONTINUED DELIVERY AND LEARNED BASAL AND MEAL NEEDS. SYMPTOMS INCLUDED HYPERGLYCEMIA WITHOUT LOSS OF CONSCIOUSNESS, DIZZINESS, KETOACIDOSIS, OR OTHER ACUTE COMPLICATIONS. OUTCOMES INCLUDED NO MEDICAL INTERVENTION, NO BACKUP THERAPY, AND NO KETONE TESTING, WITH GLUCOSE TRENDING DOWN TO 267 MG/DL ON FOLLOW-UP WHILE THE USER HAD ADEQUATE INSULIN ON BOARD. INVESTIGATION INCLUDED TROUBLESHOOTING AND EDUCATION ON ILET ADAPTATION TO BASAL AND MEAL REQUIREMENTS. INVESTIGATION OF THIS CASE REVEALED NO DEVICE MALFUNCTION OR ALARM BEHAVIOR AND THAT THE EVENT WAS CONSISTENT WITH EXPECTED GLYCEMIC VARIABILITY DURING EARLY ADAPTATION WHEN HIGH CARBOHYDRATE INTAKE OCCURRED. IT WAS CONCLUDED, BASED ON PREVIOUSLY ESTABLISHED FINDINGS FOR SIMILAR REPORTS, THAT THE CAUSE WAS UNCLEAR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
487313 ILET BIONIC PANCREAS ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP QFG BETA BIONICS INC. BB1001 00850050080183

Patients

Seq Age Sex Outcome Treatment
1 55 YR Unknown